| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Payments for leasehold improvements | 383,539 | 375,008 |
| Payments for construction in progress | 4,976,312 | 1,031,264 |
| Net cash provided by investing activities | 54,391,021 | 38,440,000 |
| Proceeds from exercise of stock awards and warrants | 76,884 | 69,934 |
| Net cash provided by financing activities | 76,884 | 69,934 |
| Net increase in cash and cash equivalents | 8,223,387 | 11,954,203 |
| Cash and cash equivalents at beginning of period | 11,286,996 | - |
| Cash and cash equivalents at end of period | 19,510,383 | - |
CAPRICOR THERAPEUTICS, INC. (CAPR)
CAPRICOR THERAPEUTICS, INC. (CAPR)